Related references
Note: Only part of the references are listed.Four-Component Staphylococcus aureus Vaccine 4C-Staph Enhances Fc gamma Receptor Expression in Neutrophils and Monocytes and Mitigates S-aureus Infection in Neutropenic Mice
Antonina Torre et al.
INFECTION AND IMMUNITY (2015)
Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus
Fabio Bagnoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study
Ali Fattom et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Recombinant ESAT-6-Like Proteins Provoke Protective Immune Responses against Invasive Staphylococcus aureus Disease in a Murine Model
Bao Zhong Zhang et al.
INFECTION AND IMMUNITY (2015)
Vaccines for the 21st century
Isabel Delany et al.
EMBO MOLECULAR MEDICINE (2014)
Staphylococcal Esx Proteins Modulate Apoptosis and Release of Intracellular Staphylococcus aureus during Infection in Epithelial Cells
Charalampia G. Korea et al.
INFECTION AND IMMUNITY (2014)
Protective Immunity against Recurrent Staphylococcus aureus Skin Infection Requires Antibody and Interleukin-17A
Christopher P. Montgomery et al.
INFECTION AND IMMUNITY (2014)
Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection
Michael R. Yeaman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study
A. Spadea et al.
VACCINE (2014)
Mining the bacterial unknown proteome: identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureus
Christina Schluepen et al.
BIOCHEMICAL JOURNAL (2013)
Structural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2
Paolo Mariotti et al.
BIOCHEMICAL JOURNAL (2013)
Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery A Randomized Trial
Vance G. Fowler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Staphylococcus aureus Alpha Toxin Suppresses Effective Innate and Adaptive Immune Responses in a Murine Dermonecrosis Model
Christine Tkaczyk et al.
PLOS ONE (2013)
Vaccine review: Staphyloccocus aureus vaccines: Problems and prospects
Kathrin U. Jansen et al.
VACCINE (2013)
Progress Toward a Staphylococcus aureus Vaccine
Robert S. Daum et al.
CLINICAL INFECTIOUS DISEASES (2012)
Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature
A. H. Shadyab et al.
HIV MEDICINE (2012)
Staphylococcus aureus FhuD2 Is Involved in the Early Phase of Staphylococcal Dissemination and Generates Protective Immunity in Mice
Ravi P. N. Mishra et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Immunization withStaphylococcus aureusiron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model
Amita Joshi et al.
Human Vaccines & Immunotherapeutics (2012)
Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials
Fabio Bagnoli et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2012)
Influenza A Inhibits Th17-Mediated Host Defense against Bacterial Pneumonia in Mice
Anupa Kudva et al.
JOURNAL OF IMMUNOLOGY (2011)
Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Anne Puel et al.
SCIENCE (2011)
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
John S. Cho et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Targeting of Alpha-Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model
Adam D. Kennedy et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Differential Roles of Interleukin-17A and-17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
Harumichi Ishigame et al.
IMMUNITY (2009)
Anti-Alpha-Hemolysin Monoclonal Antibodies Mediate Protection against Staphylococcus aureus Pneumonia
Brook E. Ragle et al.
INFECTION AND IMMUNITY (2009)
Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice
Lin Lin et al.
PLOS PATHOGENS (2009)
Immunological Mechanisms Underlying the Genetic Predisposition to Severe Staphylococcus aureus Infection in the Mouse Model
Maren von Kockritz-Blickwede et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Vaccine protection against Staphylococcus aureus pneumonia
Juliane Bubeck Wardenburg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Joshua D. Milner et al.
NATURE (2008)
EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections
ML Burts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.
H Shinefield et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Identification and characterization of fhuD1 and fhuD2, two genes involved in iron-hydroxamate uptake in Staphylococcus aureus
MT Sebulsky et al.
JOURNAL OF BACTERIOLOGY (2001)
Share Paper
